|
|
||||||||
ORIGINAL ARTICLE |
1 Dept of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center
2 Dept of Physiology, Tulane University Medical Center, New Orleans, LA 70112
* To whom correspondence should be addressed. E-mail: hboulr{at}lsuhsc.edu.
| Abstract |
|---|
iNOS inhibition was recently shown to exert no effect on allergen-challenge in human asthma, raising serious concerns about the role of the protein in the disease. Aim: We investigated the role of iNOS in ovalbumin-induced eosinophilia from the perspective of its relationship with poly(ADP-ribose) polymerase-1 (PARP-1) and oxidative DNA damage.
A mouse model of ovalbumin-induced eosinophilia was used to conduct the studies.
iNOS-associated protein nitration and tissue damage were partially responsible for allergen-induced eosinophilia. iNOS expression was required for oxidative DNA damage and PARP-1 activation upon allergen challenge. PARP-1 was required for iNOS expression and protein nitration, and this requirement was connected to NF-
B. PARP-1 was an important substrate for iNOS-associated byproducts after ovalbumin-challenge. PARP-1 nitration blocked its poly(ADP-ribosyl)ation activity. IL-5-reestablishment in ovalbumin-exposed PARP-1
/
mice reversed eosinophilia and partial mucus production without a reversal of iNOS expression, concomitant protein nitration, or associated DNA damage.
Our results demonstrate a reciprocal relationship between iNOS and PARP-1 and suggest that expression of iNOS may be dispensable for eosinophilia after IL-5 production. iNOS may be required for oxidative DNA damage and full manifestation of mucus production. Such dispensability may explain, in part, the reported ineffectiveness of iNOS inhibition in preventing allergen-induced inflammation in humans.
Keywords: Allergy, cytokines, eosinophils, inflammation, lung, transgenic/knockout mice
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |